Effectiveness of Pre-emptive Analgesics on Post-Operative Pain After Stainless Steel Crown Placement On Primary Molars
Overview
- Phase
- Phase 4
- Intervention
- Ibuprofen
- Conditions
- Post-operative Pain
- Sponsor
- Alexandria University
- Enrollment
- 66
- Locations
- 1
- Primary Endpoint
- Post-operative pain evaluation
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The aim of this study is to evaluate the effectiveness of pre-emptive analgesia using ibuprofen and paracetamol on reducing post-operative pain following the placement of stainless steel crowns on primary molars compared to placebo
Detailed Description
The study will be a parallel, placebo-controlled, triple-blinded, randomized clinical trial. A total of 66 healthy children aged 5-8 years requiring the placement of a stainless steel crown will be selected from Pediatric Dentistry and Dental Public Health Department, Faculty of Dentistry, Alexandria University, Egypt. The children will be randomly allocated into three groups according to the type of pre-emptive solution used. Group I will receive ibuprofen, group II will receive paracetamol, while group III (control) will receive a placebo solution. Children will self-report their level of pain using a Visual analogue scale (VAS) and/or a Facial pain scale (FPS) after local anesthesia administration, immediately after the cementation of the stainless steel crown, and 2, 6 and 24 hours post-operatively. Children's baseline anxiety and parental anxiety will also be assessed.
Investigators
Farah Nemr
Instructor
Alexandria University
Eligibility Criteria
Inclusion Criteria
- •Participant inclusion criteria:
- •Age range 5 to 8 years old
- •Children without any previous interventional dental experience
- •Children free of any systemic disease or special health care needs (ASA 1)
- •Children free of any allergies or hypersensitivity reactions to local anesthetics or analgesic drugs
- •Positive or definitely positive behaviour during preoperative assessments according to the Frankl Rating Scale (score 3 or 4)
- •Parents/caregivers and children who are willing to participate in the study
- •Tooth inclusion criteria:
- •Maxillary first or second primary molar teeth with extensive and/or multisurface caries where other restorations are likely to fail but without pulp exposure
- •Absence of clinical and radiographic signs or symptoms of irreversible pulpitis
Exclusion Criteria
- Not provided
Arms & Interventions
Group I (Ibuprofen)
Participants will receive ibuprofen 100 mg/5 ml (BRUFEN®, Kahira Pharmaceuticals \& Chemical Industries Co.) The solution will be administered Once, 1 hour prior to the local anesthesia administration. The participant will receive a weight-dosed volume Effective dosages range from 10 mg/kg/day to a maximum of 40 mg/kg/day
Intervention: Ibuprofen
Group II (Paracetamol)
Participants will receive paracetamol 250 mg/5 ml (CETAL®, EGYPTIAN INT. PHARMACEUTICAL INDUSTRIES CO.) The solution will be administered once, 1 hour prior to the local anesthesia administration. The participant will receive a weight-dosed volume Effective dosages are between 15-20mg/kg/day to a maximum of 60 mg/kg/day
Intervention: Paracetamol
Group III (Placebo)
The placebo solution will be freshly prepared by an assistant in a manner to match the color and odor of the analgesics
Intervention: Placebo
Outcomes
Primary Outcomes
Post-operative pain evaluation
Time Frame: Day1 (24 hours post-operatively)
Pain will be measured via a visual analogue scale (VAS) based on a straight line of 100 mm where 0 mm indicates absence of pain and 100 mm indicates greatest pain felt, and a facial pain scale.Children will self-report their level of pain four times post-operatively
Secondary Outcomes
- Trans-operative pain evaluation(Day 0 (During Procedure))
- Evaluation of parental anxiety(Day 0 (In the waiting room before the intervention))
- Evaluation of the child's dental anxiety(Day0 (In the waiting room before the intervention))